Literature DB >> 16622743

Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma.

Shinji Tanaka1, Shigeki Arii.   

Abstract

Hepatocellular carcinoma (HCC) is well known as a typical angiogenic tumor, especially in the moderately to poorly differentiated type. Such clinicopathological characteristics are not only useful for imaging diagnosis but are also applicable to the treatment of HCC. In addition, recent molecular studies have revealed that angiogenesis is closely related to hepatocarcinogenesis. In this review, the molecular mechanism of HCC angiogenesis and the antiangiogenic prevention of HCC are reviewed to introduce the latest trends in antiangiogenic treatment of cancers, including HCC.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16622743     DOI： 10.1007/s10147-006-0566-5

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


  100 in total

1.  TWEAK induces liver progenitor cell proliferation.

Authors:  Aniela Jakubowski; Christine Ambrose; Michael Parr; John M Lincecum; Monica Z Wang; Timothy S Zheng; Beth Browning; Jennifer S Michaelson; Manfred Baetscher; Manfred Baestcher; Bruce Wang; D Montgomery Bissell; Linda C Burkly
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

Review 2.  Angiogenesis and hepatocellular carcinoma.

Authors:  David Semela; Jean-François Dufour
Journal:  J Hepatol       Date:  2004-11       Impact factor: 25.083

Review 3.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

4.  Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases.

Authors:  Jennifer J Marler; Joshua B Rubin; Nikolaus S Trede; Susan Connors; Holcombe Grier; Joseph Upton; John B Mulliken; Judah Folkman
Journal:  Pediatrics       Date:  2002-02       Impact factor: 7.124

Review 5.  New oral chemotherapeutic agents for lung cancer.

Authors:  E M Bengtson; J R Rigas
Journal:  Drugs       Date:  1999       Impact factor: 9.546

6.  Angiopoietin-2 stimulates migration of endothelial progenitors and their interaction with endothelium.

Authors:  Kathryn A Gill; Nicholas P J Brindle
Journal:  Biochem Biophys Res Commun       Date:  2005-10-21       Impact factor: 3.575

7.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

8.  ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, shows antimetastatic activity using a hepatocellular carcinoma model.

Authors:  Mitsuhiro Matsuo; Hiroaki Sakurai; Ikuo Saiki
Journal:  Mol Cancer Ther       Date:  2003-06       Impact factor: 6.261

9.  Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines.

Authors:  S Majewski; A Szmurlo; M Marczak; S Jablonska; W Bollag
Journal:  Int J Cancer       Date:  1994-04-01       Impact factor: 7.396

10.  A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma.

Authors:  K Dalhoff; J Dancey; L Astrup; T Skovsgaard; K J Hamberg; F J Lofts; O Rosmorduc; S Erlinger; J Bach Hansen; W P Steward; T Skov; F Burcharth; T R J Evans
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640
View more
  14 in total

Review 1.  Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science.

Authors:  Shinji Tanaka; Shigeki Arii
Journal:  Int J Clin Oncol       Date:  2010-05-27       Impact factor: 3.402

2.  Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.

Authors:  Xiao-Yun Zhang; Yan Luo; Tian-Fu Wen; Li Jiang; Chuan Li; Xiao-Fei Zhong; Jing-Yi Zhang; Wen-Wu Ling; Lu-Nan Yan; Yong Zeng; Hong Wu
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 3.  Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies.

Authors:  Shinji Tanaka; Shigeki Arii
Journal:  J Gastroenterol       Date:  2011-02-25       Impact factor: 7.527

4.  Co-expression Network Analysis Identified COL8A1 Is Associated with the Progression and Prognosis in Human Colon Adenocarcinoma.

Authors:  Jian Shang; Fan Wang; Pengfei Chen; Xiaobing Wang; Feng Ding; Shi Liu; Qiu Zhao
Journal:  Dig Dis Sci       Date:  2018-03-01       Impact factor: 3.199

5.  Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin.

Authors:  Massimo Dal Monte; Davide Martini; Chiara Ristori; Danilo Azara; Chiara Armani; Alberto Balbarini; Paola Bagnoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-04-28       Impact factor: 3.000

6.  Endocan expression correlated with poor survival in human hepatocellular carcinoma.

Authors:  Geng-Wen Huang; Yi-Ming Tao; Xiang Ding
Journal:  Dig Dis Sci       Date:  2008-07-01       Impact factor: 3.199

7.  Exosome-derived SNHG16 sponging miR-4500 activates HUVEC angiogenesis by targeting GALNT1 via PI3K/Akt/mTOR pathway in hepatocellular carcinoma.

Authors:  Shuangda Li; Yu Qi; Yiran Huang; Yanru Guo; Tong Huang; Li Jia
Journal:  J Physiol Biochem       Date:  2021-08-23       Impact factor: 4.158

8.  Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma.

Authors:  Keisuke Nakao; Shinji Tanaka; Tomoya Miura; Kota Sato; Satoshi Matsumura; Arihiro Aihara; Yusuke Mitsunori; Daisuke Ban; Takanori Ochiai; Atsushi Kudo; Shigeki Arii; Minoru Tanabe
Journal:  Cancer Sci       Date:  2015-06-25       Impact factor: 6.716

9.  Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin.

Authors:  Damien Destouches; Diala El Khoury; Yamina Hamma-Kourbali; Bernard Krust; Patricia Albanese; Panagiotis Katsoris; Gilles Guichard; Jean Paul Briand; José Courty; Ara G Hovanessian
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

Review 10.  Imagiological Diagnosis of Gastrointestinal Diseases - Diagnostic Criteria of Hepatocellular Carcinoma.

Authors:  Pedro Boal Carvalho; Eduardo Pereira
Journal:  GE Port J Gastroenterol       Date:  2015-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.